| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthetic peptide corresponding to a sequence at the N-terminus of human ODF1 was used as the immunogen for the ODF1 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
ODF1 Antibody / Outer dense fiber protein 1 is a anti-ODF1 Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), Flow cytometry (FACS) with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: ODF1
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, FACS
Biological background
Structurally, ODF1 is a ~27 kDa coiled-coil protein with leucine zipper motifs that promote oligomerization. It is one of the earliest proteins incorporated into outer dense fibers during spermatid differentiation. ODF1 interacts with other outer dense fiber proteins such as ODF2 and with axonemal microtubules, forming the cytoskeletal backbone of the sperm tail.
Functionally, ODF1 contributes to sperm motility by reinforcing the axoneme and supporting energy transmission along the flagellum. Loss of ODF1 leads to structural abnormalities in the sperm tail and impaired motility, resulting in infertility. Researchers use ODF1 antibody to study spermatogenesis, sperm structure, and male fertility.
Clinically, ODF1 mutations or dysregulation have been associated with asthenozoospermia and male infertility. Studies in mice show that ODF1 knockout results in male sterility due to defective sperm tails. Because sperm tail defects are a common cause of infertility, ODF1 is a biomarker of reproductive health.
Experimentally, ODF1 antibody is used in western blotting to detect the ~27 kDa protein, in immunofluorescence to visualize sperm tail localization, and in immunohistochemistry of testicular sections. Co-immunoprecipitation with ODF1 antibody reveals interactions with cytoskeletal partners critical for flagellar integrity.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
